HEALTH | INSIDE AFRICA

Nigeria has detected its first case of imported Ebola Bundibugyo virus disease in the current regional outbreak, putting health authorities on alert as they trace contacts of an infected woman in Abuja who recently traveled to Uganda.

The World Health Organization said Tuesday that Nigeria had notified it of the confirmed case, making it the fifth country to detect the virus since an outbreak was declared in the Democratic Republic of the Congo on May 15.

The case comes as the outbreak in the DRC–which currently stands at nearly 10,000 confirmed cases and 4,690 deaths, as of the time of this publication, a case fatality rate of about 48.1%, —continues to spread across borders, testing public health surveillance systems and prompting a broader international response.

The WHO declared the outbreak a public health emergency of international concern in May, citing the risk of further cross-border transmission.

Nigeria’s Federal Ministry of Health and Social Welfare said the patient’s symptoms began on Oct. 7, four days after she arrived in Nigeria. She sought treatment at a private health facility in Abuja on Oct. 11, and laboratory tests confirmed the infection on Oct. 20. She is currently in isolation and receiving medical care.

Authorities are investigating the likely source of the infection and tracing the woman’s travel and exposure history.

The ministry said 44 contacts have been identified and are being monitored as health officials work to locate others who may have been exposed. Infection prevention and control measures have also been strengthened at the private facility where the patient sought treatment.

The Nigeria Centre for Disease Control and Prevention has activated its incident management system to coordinate the response, with rapid case identification, contact tracing, and infection control central to efforts to prevent further transmission.

The WHO and its partners are also supporting Nigerian health authorities with case investigations, contact tracing, infection prevention and control, and essential supplies, including personal protective equipment for health workers.

Regional Spread Raises Economic Concerns

Nigeria’s case follows the detection of the virus in other countries connected to the DRC outbreak. Kenya, which confirmed its first case on Oct. 6 in a man who had traveled from the DRC through Uganda, has reported nine confirmed cases, including one death, by Oct. 20, according to Kenya’s Health Ministry. The cases included family contacts and health workers exposed to the initial patient.

Uganda, which reported its first imported DRC Ebola case, declared its Ebola outbreak over on July 28 after completing the 42-day mandatory monitoring period after 20 reported cases. However, the two regional cases in Kenya and Nigeria have connections to Uganda through travel.

The current DRC Ebola outbreak has also traveled beyond Africa’s borders. France in late June reported an imported case, underscoring potential international spread.

The WHO continues to monitor the international spread and coordinate preparedness measures with affected and at-risk countries.

Currently, there is no approved vaccine or treatment for the Bundibugyo Ebola virus, a rare Ebola species, which makes early detection, isolation, contact tracing, and infection prevention particularly important.

Global Response Gathers Momentum

The spread has also prompted a coordinated response from African health authorities and international partners, including the WHO, the Africa Centers for Disease Control and Prevention, and major donors.

In June, G7 leaders called for a coordinated response to the outbreak in the DRC and Uganda, emphasizing the challenges posed by conflict, difficult access to affected communities, and the lack of fully effective vaccines, diagnostics, and therapies for the strain. The leaders also called for better coordination among response agencies and stronger cross-border preparedness.

That effort expanded in September, when the United States convened a G20 Foreign Ministers’ meeting during United Nations General Assembly meetings, focused on mobilizing resources and coordinating the international response. The G20 and other major donors announced more than $470 million in new commitments, bringing total global pledges since the outbreak began to more than $2 billion, according to the G20 chair’s statement.

The immediate challenge for Nigeria and other countries at risk is identifying infections quickly and preventing imported cases from triggering wider transmission.

The stakes are especially high for governments in the region and beyond as the year-end business and holiday travel and spending seasons, which support activities across major industries including aviation, hospitality, entertainment, transport, and retail, approach.

As one of Africa’s largest economies and a major business destination for international business, the arrival of an Ebola case in Nigeria carries significant implications beyond public health. While an imported case is not an indication of a widespread outbreak, a failure to contain the virus immediately would have significant consequences beyond the areas where the infections are confirmed.

Nigeria’s successful containment of the Ebola outbreak in 2014 however offers a precedent and confidence, but given the current Ebola virus’s unique strain, the current situation also presents a fresh test of the country’s public-health preparedness.

Since May, the WHO has urged countries to maintain strong disease surveillance, ensure laboratories can safely test suspected cases, keep rapid-response teams ready, and reinforce infection prevention in both public and private health facilities.

The agency also advised against imposing travel or trade restrictions on affected countries, while continuing to monitor the situation and reassess its risk assessment as new information emerges.

A swift transparent and effective response will be critical not only to preventing further infection but also to maintaining public confidence and protecting Nigeria’s reputation as a destination for business and investment. Any uncertainty or delay in containing the infection right away could affect business travel, commercial activity, and investor confidence and can prompt companies to reconsider travel, consumers to avoid crowded venues, and investors to delay decisions as they assess the risks.